Full text is available at the source.
Abstract
An integrated systematic review and meta-analysis evaluated the effects of GLP-1 receptor agonists on heart failure.
- GLP-1 receptor agonists are associated with reduced cardiovascular risk in patients with type 2 diabetes mellitus.
- Evidence regarding their impact on heart failure has been growing but remains fragmented.
- The analysis examined various trial populations and heart failure phenotypes.
- Complementary trial-level and phenotype-based approaches were used to assess the effects.
Simplified